<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Increase in FDI in Pharmaceutical Sector</title>
    <link>https://www.taxtmi.com/news?id=12391</link>
    <description>FDI policy permits 100% FDI on the automatic route for greenfield projects and 100% for brownfield projects under the government approval route subject to conditionalities to ensure medicine availability and R&amp;D. Non compete clauses are disallowed except in special cases with Foreign Investment Promotion Board approval. Drug Price Control Order and the National Pharmaceutical Pricing Authority are cited as mechanisms to safeguard affordability and availability.</description>
    <language>en-us</language>
    <pubDate>Wed, 12 Feb 2014 17:19:57 +0530</pubDate>
    <lastBuildDate>Wed, 12 Feb 2014 17:19:57 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=345731" rel="self" type="application/rss+xml"/>
    <item>
      <title>Increase in FDI in Pharmaceutical Sector</title>
      <link>https://www.taxtmi.com/news?id=12391</link>
      <description>FDI policy permits 100% FDI on the automatic route for greenfield projects and 100% for brownfield projects under the government approval route subject to conditionalities to ensure medicine availability and R&amp;D. Non compete clauses are disallowed except in special cases with Foreign Investment Promotion Board approval. Drug Price Control Order and the National Pharmaceutical Pricing Authority are cited as mechanisms to safeguard affordability and availability.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 12 Feb 2014 17:19:57 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=12391</guid>
    </item>
  </channel>
</rss>